Was wir denken

Erfahren Sie mehr über unsere neuesten Einblicke, Ideen und Perspektiven. Hier finden Sie einen Ausblick auf unserer aktuellen Erkenntnisse und Denkanstöße für verschiedene Industrien und Branchen.

Trending Topics

The Growth Blueprint podcast
Automotive Study
2024 Global Telecommunications Study results
Global Pricing Study 2025
Tariffs, pricing, and power
Better Growth in Retail and SME Banking
Wie kommen Unternehmen durch eine mögliche Rezession?
Durch Revenue Growth Management neue Wachstumspotenziale erschließen
Better Growth
Deutschland
hospital
März 05, 2025 | Blog

Deutsche Krankenhausreform: Implikationen für Medtech-Unternehmen

Healthcare & Life Sciences Digital Health & Health IT
Deutschland
hospital
März 05, 2025 | Blog

Deutsche Krankenhausreform: Maßnahmen für Medtech-Unternehmen

Healthcare & Life Sciences Digital Health & Health IT
Deutschland
latest report by Simon-Kucher and the German Association of Research-Based Pharmaceutical Companies (vfa)
Jan. 06, 2025 | Perspective | Report

Die Bedeutung der Orphan Drug-Regelung im AMNOG für die Patientenversorgung

Healthcare & Life Sciences Pharma & Biotechnologie
United States
US P&MA
Jan. 13, 2026 | Blog

US drug pricing in 2026: A new era

Healthcare & Life Sciences Pharma & Biotechnology
Simon-Kucher insights_Strategic indication-selection for early drug development
Jan. 05, 2026 | Perspective | Whitepaper

Strategic indication-selection for early-stage drug development

Healthcare & Life Sciences Pharma & Biotechnology
China
blog_China_NRDL_Readout
Dez. 19, 2025 | Blog

NRDL 2025 readout: New listings

Healthcare & Life Sciences
Healthcare and life sciences trends 2026
Dez. 16, 2025 | Blog

Healthcare and life sciences trends 2026

Healthcare & Life Sciences Pharma & Biotechnology
United States
Simon-Kucher insights: Winners from the latest IRA price negotiation round
Dez. 15, 2025 | Blog

Winners from the latest IRA price negotiation round

Healthcare & Life Sciences Pharma & Biotechnology
Christian and Robert
Dez. 11, 2025 | Multimedia

MFN, EU JCA & Equitable access: 2026 global pharma and biotech

Healthcare & Life Sciences Medtech
Six watchouts for pharma
Dez. 11, 2025 | Blog

Six watchouts for pharma in precision medicine

Healthcare & Life Sciences Diagnostics
United States
Simon-Kucher insights: Comparing IPAY 2027 to IPAY 2026 outcomes
Dez. 03, 2025 | Blog

Comparing IPAY 2027 to IPAY 2026 outcomes

Healthcare & Life Sciences Pharma & Biotechnology
Simon-Kucher insights: Rethinking healthcare access in emerging markets
Nov. 26, 2025 | Blog

Rethinking healthcare access in emerging markets

Healthcare & Life Sciences Pharma & Biotechnology
mfn
Nov. 26, 2025 | Blog

Medicare MFPs versus MFN Pricing

Healthcare & Life Sciences Pharma & Biotechnology
China
Simon-Kucher insights: Navigating Volume-Based Procurement in China
Nov. 24, 2025 | Blog

Navigating volume-based procurement in China

Healthcare & Life Sciences Pharma & Biotechnology
Simon-Kucher Blog: How smarter CPQ integration within RMS closes the diagnostics profit gap
Nov. 19, 2025 | Blog

Smarter CPQ integration prevents diagnostics revenue leakage

Healthcare & Life Sciences Diagnostics
Simon-Kucher insights: Rewiring medtech operating models for the digital era
Nov. 17, 2025 | Blog

Rewiring medtech operating models for the digital era

Healthcare & Life Sciences Medtech
Language
Search